| Solvay Pharma India has reported a sales turnover of Rs 80.89 crore and a net profit of Rs 11.21 crore for the quarter ended Mar '11. | | For the quarter ended Mar 2010 the sales turnover was Rs 62.75 crore and net profit was Rs 11.29 crore. |
|
| | Quarterly Results of Solvay Pharma India | -------- in Rs. Cr. -------- |
|
| Mar '10 | | | Dec '10 | Mar '11 | | Sales Turnover | 62.75 | | | 76.03 | 80.89 | | Other Income | 0.75 | | | 1.06 | 1.52 | | Total Income | 63.50 | | | 77.09 | 82.41 | | Total Expenses | 45.68 | | | 66.24 | 59.53 | | Operating Profit | 17.07 | | | 9.79 | 21.36 | | Profit On Sale Of Assets | -- | | | -- | -- | | Profit On Sale Of Investments | -- | | | -- | -- | | Gain/Loss On Foreign Exchange | -- | | | -- | -- | | VRS Adjustment | -- | | | -- | -- | | Other Extraordinary Income/Expenses | -- | | | -- | -- | | Total Extraordinary Income/Expenses | -- | | | -- | -5.64 | | Tax On Extraordinary Items | -- | | | -- | -- | | Net Extra Ordinary Income/Expenses | -- | | | -- | -- | | Gross Profit | 17.82 | | | 10.85 | 22.88 | | Interest | -- | | | -- | -- | | PBDT | 17.82 | | | 10.86 | 17.24 | | Depreciation | 0.79 | | | 0.82 | 0.73 | | Depreciation On Revaluation Of Assets | -- | | | -- | -- | | PBT | 17.03 | | | 10.04 | 16.51 | | Tax | 5.74 | | | 3.13 | 5.30 | | Net Profit | 11.29 | | | 6.91 | 11.21 | | Prior Years Income/Expenses | -- | | | -- | -- | | Depreciation for Previous Years Written Back/ Provided | -- | | | -- | -- | | Dividend | -- | | | -- | -- | | Dividend Tax | -- | | | -- | -- | | Dividend (%) | -- | | | -- | -- | | Earnings Per Share | 22.36 | | | 13.68 | 22.20 | | Book Value | -- | | | -- | -- | | Equity | 5.05 | | | 5.05 | 5.05 | | Reserves | -- | | | -- | -- | | Face Value | 10.00 | | | 10.00 | 10.00 | | Source : Religare Technova |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
